Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study

[1]  Communities.  English Indices of Deprivation 2015 - LSOA Level , 2018 .

[2]  R. Sullivan,et al.  Balancing Equity and Advancement: The Role of Health Technology Assessment in Radiotherapy Resource Allocation. , 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  M. Mason,et al.  Patient mobility for radical prostatectomy in the English NHS: its impact on service configuration and technology integration , 2017 .

[4]  L. Siciliani,et al.  Policies towards hospital and GP competition in five European countries. , 2017, Health policy.

[5]  M. Mason,et al.  Patient Mobility for Elective Secondary Health Care Services in Response to Patient Choice Policies: A Systematic Review , 2016, Medical care research and review : MCRR.

[6]  Lord Bourne,et al.  Department for Communities and Local Government: Troubled families programme: transforming the lives of thousands of families , 2016 .

[7]  Jim C Hu,et al.  Use, complications, and costs of stereotactic body radiotherapy for localized prostate cancer , 2016, Cancer.

[8]  J. Rashbass,et al.  Organisation of Prostate Cancer Services in the English National Health Service. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).

[9]  Annie Gao,et al.  Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial , 2016, The Lancet. Oncology.

[10]  S. Nass,et al.  Appropriate Use of Advanced Technologies for Radiation Therapy and Surgery in Oncology: Workshop Summary , 2016 .

[11]  J. Rademakers,et al.  Why patients may not exercise their choice when referred for hospital care. An exploratory study based on interviews with patients , 2014, Health expectations : an international journal of public participation in health care and health policy.

[12]  Communities.  Index of Multiple Deprivation Score, 2010 , 2015 .

[13]  M. Calnan,et al.  A qualitative study of patient (dis)trust in public and private hospitals: the importance of choice and pragmatic acceptance for trust considerations in South Australia , 2015, BMC Health Services Research.

[14]  J. Rashbass,et al.  The National Prostate Cancer Audit – Results from the Organisational Survey of NHS Trusts in England , 2015 .

[15]  M. Cooperberg,et al.  Proton Therapy Websites: Information Anarchy Creates Confusion , 2015, BJU international.

[16]  K. Dimopoulos,et al.  Choice and Competition Between Adult Congenital Heart Disease Centers: Evidence of Considerable Geographical Disparities and Association With Clinical or Academic Results , 2014, Circulation. Cardiovascular quality and outcomes.

[17]  R. Kemp,et al.  Patient hospital choice for hip replacement: empirical evidence from the Netherlands , 2014, The European Journal of Health Economics.

[18]  David A Cromwell,et al.  Public reporting of surgeon outcomes: low numbers of procedures lead to false complacency , 2013, The Lancet.

[19]  J. Efstathiou,et al.  Physician evaluation of internet health information on proton therapy for prostate cancer. , 2013, International journal of radiation oncology, biology, physics.

[20]  L. Siciliani,et al.  Hospital quality competition under fixed prices , 2012 .

[21]  W P M Mayles,et al.  Progress with Intensity-modulated radiotherapy implementation in the UK. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  J. Rademakers,et al.  Determinants of patient choice of healthcare providers: a scoping review , 2012, BMC Health Services Research.

[23]  W. Beckert,et al.  Choice of NHS�?Funded Hospital Services in England , 2012 .

[24]  Ronald C. Chen,et al.  Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. , 2012, JAMA.

[25]  T. Skolarus,et al.  Growth of high-cost intensity-modulated radiotherapy for prostate cancer raises concerns about overuse. , 2012, Health affairs.

[26]  C. Grau,et al.  Health economics in radiation oncology: introducing the ESTRO HERO project. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  Todd Pawlicki,et al.  An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  J. V. van Loon,et al.  Evaluation of novel radiotherapy technologies: what evidence is needed to assess their clinical and cost effectiveness, and how should we get it? , 2012, The Lancet. Oncology.

[29]  F. Schut,et al.  Do patients choose hospitals with high quality ratings? Empirical evidence from the market for angioplasty in the Netherlands. , 2012, Journal of health economics.

[30]  P. Warde,et al.  Intensity-modulated radiotherapy in the treatment of prostate cancer. , 2012, Clinical oncology (Royal College of Radiologists (Great Britain)).

[31]  G. Bevan,et al.  Does competition between hospitals improve clinical quality? A review of evidence from two eras of competition in the English NHS , 2011, BMJ : British Medical Journal.

[32]  S. Lipsitz,et al.  Cost implications of the rapid adoption of newer technologies for treating prostate cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Brundage,et al.  Development of indicators of the quality of radiotherapy for localized prostate cancer. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  J. van der Meulen,et al.  Identifying co‐morbidity in surgical patients using administrative data with the Royal College of Surgeons Charlson Score , 2010, The British journal of surgery.

[35]  K. Hill.  Simple guide to payment by results , 2009 .

[36]  John D. Donahue,et al.  :The Other Invisible Hand: Delivering Public Services through Choice and Competition , 2008 .

[37]  L. Anderson.  Index of Multiple Deprivation , 2008 .

[38]  M. Parmar,et al.  Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. , 2007, The Lancet. Oncology.

[39]  Marco Varkevisser,et al.  Why do patients bypass the nearest hospital? An empirical analysis for orthopaedic care and neurosurgery in the Netherlands , 2007, The European Journal of Health Economics.

[40]  S. Ramsey,et al.  Why do men choose one treatment over another? , 2006, Cancer.

[41]  J. Roeske,et al.  Intensity‐modulated radiotherapy and the Internet , 2004, Cancer.

[42]  P. Carroll.  Quality-of-care indicators for early-stage prostate cancer , 2003 .

[43]  Michelle Brasure,et al.  Understanding rural hospital bypass behavior. , 2003, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[44]  Benjamin A Spencer,et al.  Quality-of-care indicators for early-stage prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  J. Birkmeyer,et al.  Hospital volume and surgical mortality in the United States. , 2002, The New England journal of medicine.

[46]  J. Weissman,et al.  Teaching hospitals and quality of care: a review of the literature. , 2002, The Milbank quarterly.

[47]  R. Centor,et al.  Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI. , 2000, JAMA.

[48]  D. Whellan,et al.  Effects of admission to a teaching hospital on the cost and quality of care for Medicare beneficiaries. , 1999, The New England journal of medicine.

[49]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .

[50]  A. Renshaw,et al.  Biochemical Outcome after radical prostatectomy, external beam Radiation Therapy, or interstitial Radiation therapy for clinically localized prostate cancer , 1998 .

[51]  D Draper,et al.  Hospital characteristics and quality of care. , 1992, JAMA.

[52]  D. McFadden.  Conditional logit analysis of qualitative choice behavior , 1972 .

[53]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.